Cystathionine Beta Synthase

CU with Orphan Technologies to Develop an Enzyme Replacement Therapy
Feb 25, 2013
The University of Colorado (CU) has signed an exclusive, worldwide licensing and collaboration agreements with Orphan Technologies to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria. ...

Tags: Orphan Technologies, homocystinuria, Cystathionine Beta Synthase